Diabetic patients with COVID-19: low antibody levels linked to worse outcomes

The role of anti-SARS-CoV-2 antibody levels on COVID-19 outcomes in patients with T2D.

Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference | Psychedelic Invest

SARASOTA, FL, July 26, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing

July 26, 2024

$200 million gift guarantees tuition-free medical education at NYU Grossman Long Island School of Medicine

A transformative $200 million gift to NYU Long Island School of Medicine will ensure generations of medical students continue to receive a tuition-free, top-quality education

July 21, 2023

Gene Therapy Promising for Rare Jaundice Syndrome

Gene therapy for Crigler-Najjar syndrome appeared promising in patients treated at a higher dose, a phase I/II trial showed. A single infusion of GNT0003 —

August 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.